https://informatiestandaarden.nictiz.nl/index.php?action=history&feed=atom&title=mp%3AMedicatieoverdracht_Volgende_draft 2026-05-03T00:08:41Z Bewerkingsoverzicht voor deze pagina op de wiki MediaWiki 1.31.16 https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254430&oldid=prev 2025-03-27T13:45:33Z

<p>‎<span dir="auto"><span class="autocomment">Testproces</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:45</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l235" >Regel 235:</td> <td colspan="2" class="diff-lineno">Regel 235:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Zoals in bovenstaande weergave doorloopt de leverancier de volgende testfasen: &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Zoals in bovenstaande weergave doorloopt de leverancier de volgende testfasen: &#160;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Ontwikkelfase| <del class="diffchange diffchange-inline">&lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''</del>Ontwikkeltest<del class="diffchange diffchange-inline">'''</del>]]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Ontwikkelfase| Ontwikkeltest]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Proof_of_Concept_(PoC)| <del class="diffchange diffchange-inline">&lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''</del>Proof of Concept (PoC)<del class="diffchange diffchange-inline">'''</del>]]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Proof_of_Concept_(PoC)| Proof of Concept (PoC)]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Laboratoriumtest| <del class="diffchange diffchange-inline">&lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''</del>Laboratoriumtest<del class="diffchange diffchange-inline">'''</del>]]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Laboratoriumtest| Laboratoriumtest]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Validatie_MO| <del class="diffchange diffchange-inline">&lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''</del>Validatie<del class="diffchange diffchange-inline">'''</del>]]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Validatie_MO| Validatie]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Praktijktest| <del class="diffchange diffchange-inline">&lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''</del>Praktijktest<del class="diffchange diffchange-inline">'''</del>]]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart_Praktijktest| Praktijktest]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Onderstaande documenten bieden ondersteuning tijdens de testfasen:</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Onderstaande documenten bieden ondersteuning tijdens de testfasen:</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254429&oldid=prev 2025-03-27T13:44:38Z

<p>‎<span dir="auto"><span class="autocomment">Testproces</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:44</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l234" >Regel 234:</td> <td colspan="2" class="diff-lineno">Regel 234:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Zoals in bovenstaande weergave doorloopt de leverancier de volgende testfasen: </ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">:*[[mp:Testen_Kickstart_Ontwikkelfase| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Ontwikkeltest''']]</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">:*[[mp:Testen_Kickstart_Proof_of_Concept_(PoC)| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Proof of Concept (PoC)''']]</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">:*[[mp:Testen_Kickstart_Laboratoriumtest| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Laboratoriumtest''']]</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">:*[[mp:Validatie_MO| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Validatie''']]</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">:*[[mp:Testen_Kickstart_Praktijktest| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Praktijktest''']]</ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">Onderstaande documenten bieden ondersteuning tijdens de testfasen:</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart|Testinformatie Kickstart]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Testen_Kickstart|Testinformatie Kickstart]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Draft_Testtooling|Tooling &amp; omgevingen Kickstart]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Draft_Testtooling|Tooling &amp; omgevingen Kickstart]]</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254428&oldid=prev 2025-03-27T13:41:41Z

<p>‎<span dir="auto"><span class="autocomment">Testproces</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:41</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l223" >Regel 223:</td> <td colspan="2" class="diff-lineno">Regel 223:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| style=&quot;text-align:center; margin:auto; border-spacing:20px;&quot;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| style=&quot;text-align:center; margin:auto; border-spacing:20px;&quot;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Ontwikkelfase| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Ontwikkeltest''']]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Ontwikkelfase| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''<ins class="diffchange diffchange-inline">&lt;u&gt;</ins>Ontwikkeltest<ins class="diffchange diffchange-inline">&lt;/u&gt;</ins>''']]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Proof_of_Concept_(PoC)| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Proof of Concept (PoC)''']]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Proof_of_Concept_(PoC)| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''<ins class="diffchange diffchange-inline">&lt;u&gt;</ins>Proof of Concept (PoC)<ins class="diffchange diffchange-inline">&lt;/u&gt;</ins>''']]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; | [[mp:Testen_Kickstart_Laboratoriumtest| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Laboratoriumtest''']]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; | [[mp:Testen_Kickstart_Laboratoriumtest| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''<ins class="diffchange diffchange-inline">&lt;u&gt;</ins>Laboratoriumtest<ins class="diffchange diffchange-inline">&lt;/u&gt;</ins>''']]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; | [[mp:Validatie_MO| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Validatie''']]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; | [[mp:Validatie_MO| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''<ins class="diffchange diffchange-inline">&lt;u&gt;</ins>Validatie<ins class="diffchange diffchange-inline">&lt;/u&gt;</ins>''']]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; | [[mp:Testen_Kickstart_Praktijktest| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Praktijktest''']]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; | [[mp:Testen_Kickstart_Praktijktest| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''<ins class="diffchange diffchange-inline">&lt;u&gt;</ins>Praktijktest<ins class="diffchange diffchange-inline">&lt;/u&gt;</ins>''']]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254423&oldid=prev 2025-03-27T13:37:11Z

<p>‎<span dir="auto"><span class="autocomment">Testproces</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:37</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l223" >Regel 223:</td> <td colspan="2" class="diff-lineno">Regel 223:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| style=&quot;text-align:center; margin:auto; border-spacing:20px;&quot;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| style=&quot;text-align:center; margin:auto; border-spacing:20px;&quot;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Ontwikkelfase| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''<del class="diffchange diffchange-inline">Ontwikkelfase</del>''']]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Ontwikkelfase| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''<ins class="diffchange diffchange-inline">Ontwikkeltest</ins>''']]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| → &#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Proof_of_Concept_(PoC)| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Proof of Concept (PoC)''']]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#00bcd4; color:white; padding:10px 20px; border-radius:15px;&quot; |[[mp:Testen_Kickstart_Proof_of_Concept_(PoC)| &lt;span style=&quot;color:white; text-decoration:none;&quot;&gt;'''Proof of Concept (PoC)''']]</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254422&oldid=prev 2025-03-27T13:33:05Z

<p>‎<span dir="auto"><span class="autocomment">Stap 0 documentatie</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:33</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l77" >Regel 77:</td> <td colspan="2" class="diff-lineno">Regel 77:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[https://www.samenvoormedicatieoverdracht.nl/kennisbank/pva_kickstart/&lt;abbr title=&quot;Het Plan van aanpak versie 3.1 voor de uitvoering van de Kickstart. Het Plan van aanpak versie 3.1 beschrijft het doel, de opzet, aanpak en kaders voor de uitvoering van de Kickstart.&quot;&gt;Plan van aanpak versie 3.1&lt;/abbr&gt;]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[https://www.samenvoormedicatieoverdracht.nl/kennisbank/pva_kickstart/&lt;abbr title=&quot;Het Plan van aanpak versie 3.1 voor de uitvoering van de Kickstart. Het Plan van aanpak versie 3.1 beschrijft het doel, de opzet, aanpak en kaders voor de uitvoering van de Kickstart.&quot;&gt;Plan van aanpak versie 3.1&lt;/abbr&gt;]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0-beta_Ontwerp_medicatieproces_9|&lt;abbr title=&quot;Het functioneel ontwerp van de informatiestandaard Medicatieproces 9 Het beschrijft de algemene werking en specifieke praktijksituaties.&quot;&gt;Functioneel ontwerp Medicatieproces 9 versie 3.0.0-beta.4 (NL)&lt;/abbr&gt;]] / [[mp:V3.0.0-beta_Ontwerp_medicatieproces_9_ENG|Functional design Medication Process 9 version 3.0.0-beta.4 (ENG)]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0-beta_Ontwerp_medicatieproces_9|&lt;abbr title=&quot;Het functioneel ontwerp van de informatiestandaard Medicatieproces 9 Het beschrijft de algemene werking en specifieke praktijksituaties.&quot;&gt;Functioneel ontwerp Medicatieproces 9 versie 3.0.0-beta.4 (NL)&lt;/abbr&gt;]] / [[mp:V3.0.0-beta_Ontwerp_medicatieproces_9_ENG|Functional design Medication Process 9 version 3.0.0-beta.4 (ENG)]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0_Ontwerp_medicatieproces_9_voor_patient_usecases|&lt;abbr title=&quot;Functioneel Ontwerp Medicatieproces 9 versie 3.0.0-beta.4 voor patiënt usecases&quot;&gt;Functioneel <del class="diffchange diffchange-inline">Ontwerp </del>Medicatieproces 9 versie 3.0.0-beta.4 voor patiënt usecases&lt;/abbr&gt;]]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0_Ontwerp_medicatieproces_9_voor_patient_usecases|&lt;abbr title=&quot;Functioneel Ontwerp Medicatieproces 9 versie 3.0.0-beta.4 voor patiënt usecases&quot;&gt;Functioneel <ins class="diffchange diffchange-inline">ontwerp </ins>Medicatieproces 9 versie 3.0.0-beta.4 voor patiënt usecases&lt;/abbr&gt;]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[Lab:Vcurrent_Ontwerp_Lab2zorg|&lt;abbr title=&quot;Het functioneel ontwerp van Lab2zorg. In de kickstart wordt het onderdeel lab2zorg gebruikt voor het meesturen van een nierfunctiewaarde met het voorschrift.&#160; Deze usecase staat beschreven in paragraaf 2.3 van het functioneel ontwerp lab2zorg.&quot;&gt;Functioneel ontwerp Lab2zorg versie 3.0.0&lt;/abbr&gt;]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[Lab:Vcurrent_Ontwerp_Lab2zorg|&lt;abbr title=&quot;Het functioneel ontwerp van Lab2zorg. In de kickstart wordt het onderdeel lab2zorg gebruikt voor het meesturen van een nierfunctiewaarde met het voorschrift.&#160; Deze usecase staat beschreven in paragraaf 2.3 van het functioneel ontwerp lab2zorg.&quot;&gt;Functioneel ontwerp Lab2zorg versie 3.0.0&lt;/abbr&gt;]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Besluiten_kernteams|&lt;abbr title=&quot;Deze pagina bevat de besluiten van de kernteams, met (indien van toepassing) de bijbehorende werkproceseisen, gebruikerseisen en -wensen.&quot;&gt;Besluiten kernteams Medicatieproces 9, inclusief gebruikerseisen en -wensen&lt;/abbr&gt;]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Besluiten_kernteams|&lt;abbr title=&quot;Deze pagina bevat de besluiten van de kernteams, met (indien van toepassing) de bijbehorende werkproceseisen, gebruikerseisen en -wensen.&quot;&gt;Besluiten kernteams Medicatieproces 9, inclusief gebruikerseisen en -wensen&lt;/abbr&gt;]]</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254421&oldid=prev 2025-03-27T13:32:36Z

<p>‎<span dir="auto"><span class="autocomment">Stap 0 documentatie</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:32</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l86" >Regel 86:</td> <td colspan="2" class="diff-lineno">Regel 86:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[Lab:V3.0.0_FHIR_Lab2zorg|&lt;abbr title=&quot;Technische FHIR specificaties van Lab2zorg in aanvulling op het functioneel ontwerp. Paragraaf 4.3 beschrijft het sturen van laboratoriumresultaten tussen zorgverleners dat in de kickstart gebruikt wordt.&quot;&gt;FHIR Lab2zorg version 3.0.0 (ENG)&lt;/abbr&gt;]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[Lab:V3.0.0_FHIR_Lab2zorg|&lt;abbr title=&quot;Technische FHIR specificaties van Lab2zorg in aanvulling op het functioneel ontwerp. Paragraaf 4.3 beschrijft het sturen van laboratoriumresultaten tussen zorgverleners dat in de kickstart gebruikt wordt.&quot;&gt;FHIR Lab2zorg version 3.0.0 (ENG)&lt;/abbr&gt;]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0_MedicationProcess9_FHIR|&lt;abbr title=&quot;FHIR Implementation guide for Medicatieproces 9 versie 3.0.0-beta.4 FHIR in English&quot;&gt;FHIR Implementation Guide Medication Process 9 version 3.0.0-beta.4 (ENG) &lt;/abbr&gt;]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0_MedicationProcess9_FHIR|&lt;abbr title=&quot;FHIR Implementation guide for Medicatieproces 9 versie 3.0.0-beta.4 FHIR in English&quot;&gt;FHIR Implementation Guide Medication Process 9 version 3.0.0-beta.4 (ENG) &lt;/abbr&gt;]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"></del></div></td><td colspan="2">&#160;</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Verzamelbestand informatiestandaarden'''</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Verzamelbestand informatiestandaarden'''</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254419&oldid=prev 2025-03-27T13:16:15Z

<p>‎<span dir="auto"><span class="autocomment">Stap 0 documentatie</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:16</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l73" >Regel 73:</td> <td colspan="2" class="diff-lineno">Regel 73:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Stap 0 documentatie==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Stap 0 documentatie==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Na het intakegesprek kan de leverancier starten met het schrijven van de stap 0 documentatie. Ter aanvulling op de linkjes in '2.1 Voorbereiding' staan hieronder nog een aantal relevantie pagina's:</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Na het intakegesprek kan de leverancier starten met het schrijven van de stap 0 documentatie. Ter aanvulling op de linkjes in '2.1 Voorbereiding' staan hieronder nog een aantal relevantie pagina's:</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">:*[https://www.zorginzicht.nl/binaries/content/assets/zorginzicht/kwaliteitsinstrumenten/Kwaliteitsstandaard+Overdracht+van+medicatiegegevens+in+de+keten.pdf Kwaliteitsstandaard: richtlijn overdracht van medicatiegegevens in de keten]&lt;br&gt;</ins></div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Stap_0_Voorbereiding|Werkzaamheden in stap 0 Voorbereiding]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:Stap_0_Voorbereiding|Werkzaamheden in stap 0 Voorbereiding]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[https://www.samenvoormedicatieoverdracht.nl/kennisbank/pva_kickstart/&lt;abbr title=&quot;Het Plan van aanpak versie 3.1 voor de uitvoering van de Kickstart. Het Plan van aanpak versie 3.1 beschrijft het doel, de opzet, aanpak en kaders voor de uitvoering van de Kickstart.&quot;&gt;Plan van aanpak versie 3.1&lt;/abbr&gt;]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[https://www.samenvoormedicatieoverdracht.nl/kennisbank/pva_kickstart/&lt;abbr title=&quot;Het Plan van aanpak versie 3.1 voor de uitvoering van de Kickstart. Het Plan van aanpak versie 3.1 beschrijft het doel, de opzet, aanpak en kaders voor de uitvoering van de Kickstart.&quot;&gt;Plan van aanpak versie 3.1&lt;/abbr&gt;]</div></td></tr> <tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l85" >Regel 85:</td> <td colspan="2" class="diff-lineno">Regel 86:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[Lab:V3.0.0_FHIR_Lab2zorg|&lt;abbr title=&quot;Technische FHIR specificaties van Lab2zorg in aanvulling op het functioneel ontwerp. Paragraaf 4.3 beschrijft het sturen van laboratoriumresultaten tussen zorgverleners dat in de kickstart gebruikt wordt.&quot;&gt;FHIR Lab2zorg version 3.0.0 (ENG)&lt;/abbr&gt;]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[Lab:V3.0.0_FHIR_Lab2zorg|&lt;abbr title=&quot;Technische FHIR specificaties van Lab2zorg in aanvulling op het functioneel ontwerp. Paragraaf 4.3 beschrijft het sturen van laboratoriumresultaten tussen zorgverleners dat in de kickstart gebruikt wordt.&quot;&gt;FHIR Lab2zorg version 3.0.0 (ENG)&lt;/abbr&gt;]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0_MedicationProcess9_FHIR|&lt;abbr title=&quot;FHIR Implementation guide for Medicatieproces 9 versie 3.0.0-beta.4 FHIR in English&quot;&gt;FHIR Implementation Guide Medication Process 9 version 3.0.0-beta.4 (ENG) &lt;/abbr&gt;]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V3.0.0_MedicationProcess9_FHIR|&lt;abbr title=&quot;FHIR Implementation guide for Medicatieproces 9 versie 3.0.0-beta.4 FHIR in English&quot;&gt;FHIR Implementation Guide Medication Process 9 version 3.0.0-beta.4 (ENG) &lt;/abbr&gt;]]</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">:*[https://www.zorginzicht.nl/binaries/content/assets/zorginzicht/kwaliteitsinstrumenten/Kwaliteitsstandaard+Overdracht+van+medicatiegegevens+in+de+keten.pdf Kwaliteitsstandaard: richtlijn overdracht van medicatiegegevens in de keten]&lt;br&gt;</del></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Verzamelbestand informatiestandaarden'''</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Verzamelbestand informatiestandaarden'''</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254418&oldid=prev 2025-03-27T13:10:31Z

<p>‎<span dir="auto"><span class="autocomment">Testen</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:10</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l217" >Regel 217:</td> <td colspan="2" class="diff-lineno">Regel 217:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Voor alle bovenstaande testen levert het Validatieloket de testscripts aan.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Voor alle bovenstaande testen levert het Validatieloket de testscripts aan.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Om de testfase af te sluiten, levert de leverancier een testrapport aan bij het Validatieloket. Na beoordeling hiervan <del class="diffchange diffchange-inline">kan er overgegaan worden naar </del>de validatiefase.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Om de testfase af te sluiten, levert de leverancier een testrapport aan bij het Validatieloket. Na beoordeling hiervan <ins class="diffchange diffchange-inline">start </ins>de validatiefase.</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>&#160;</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Testproces==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Testproces==</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;div align=&quot;center&quot;&gt;'''Testfasen per stap'''&lt;/div&gt;</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;div align=&quot;center&quot;&gt;'''Testfasen per stap'''&lt;/div&gt;</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254417&oldid=prev 2025-03-27T13:09:14Z

<p>‎<span dir="auto"><span class="autocomment">Ontwikkelen</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:09</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l198" >Regel 198:</td> <td colspan="2" class="diff-lineno">Regel 198:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_6:_Toedienen|Stap 6: Toedienen]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_6:_Toedienen|Stap 6: Toedienen]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">Het is aan </del>de <del class="diffchange diffchange-inline">leverancier in welke </del>volgorde <del class="diffchange diffchange-inline">er ontwikkeld gaat worden</del>. Dit kan <del class="diffchange diffchange-inline">per </del>stap <del class="diffchange diffchange-inline">gedaan worden</del>, <del class="diffchange diffchange-inline">of dat </del>bijvoorbeeld stap 3 en 4 <del class="diffchange diffchange-inline">gebundeld wordt </del>en <del class="diffchange diffchange-inline">daarna </del>stap 5 en 6.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">De leverancier bepaalt </ins>de volgorde <ins class="diffchange diffchange-inline">van de ontwikkeling</ins>. Dit kan stap <ins class="diffchange diffchange-inline">voor stap gebeuren of</ins>, bijvoorbeeld<ins class="diffchange diffchange-inline">, door </ins>stap 3 en 4 <ins class="diffchange diffchange-inline">te bundelen </ins>en <ins class="diffchange diffchange-inline">vervolgens </ins>stap 5 en 6.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Criteria==</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Criteria==</div></td></tr> </table>

Maud Hellinga https://informatiestandaarden.nictiz.nl/index.php?title=mp:Medicatieoverdracht_Volgende_draft&diff=254416&oldid=prev 2025-03-27T13:08:11Z

<p>‎<span dir="auto"><span class="autocomment">Ontwikkelen</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="nl"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Oudere versie</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Versie van 27 mrt 2025 om 13:08</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l177" >Regel 177:</td> <td colspan="2" class="diff-lineno">Regel 177:</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#ff9800; color:white; padding:10px 20px;&quot; | '''Start ontwikkelfase'''</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| style=&quot;background-color:#ff9800; color:white; padding:10px 20px;&quot; | '''Start ontwikkelfase'''</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Na het intakegesprek heeft de leverancier een beeld van het proces en wat <del class="diffchange diffchange-inline">er </del>volgens de informatiestandaard MP9 gebouwd moet worden.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Na het intakegesprek heeft de leverancier een beeld van het proces en wat volgens de informatiestandaard MP9 gebouwd moet worden.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>De leverancier heeft nu de opdracht gekregen om aan de slag te gaan met het schrijven van het Plan van Aanpak (PvA), het functioneel ontwerp (FO) en het technisch ontwerp (TO).</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>De leverancier heeft nu de opdracht gekregen om aan de slag te gaan met het schrijven van het Plan van Aanpak (PvA), het functioneel ontwerp (FO) en het technisch ontwerp (TO).</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Zodra de documenten klaar zijn, levert de leverancier deze aan bij het Validatieloket. De ingeleverde documenten worden beoordeeld door Nictiz, VZVZ en de penvoerder. Zodra alles is goedgekeurd, kan worden overgegaan op de ontwikkelfase.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Zodra de documenten klaar zijn, levert de leverancier deze aan bij het Validatieloket. De ingeleverde documenten worden beoordeeld door Nictiz, VZVZ en de penvoerder. Zodra alles is goedgekeurd, kan worden overgegaan op de ontwikkelfase.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Het is tevens noodzakelijk om de conformiteitscheck in te vullen. Hierin wordt aangegeven welke functionaliteiten wel of niet worden ingebouwd of mogelijk afwijkend zijn van wat is beschreven in de informatiestandaard.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Het is tevens noodzakelijk om de conformiteitscheck in te vullen. Hierin wordt aangegeven welke functionaliteiten wel of niet worden ingebouwd of mogelijk afwijkend zijn van wat is beschreven in de informatiestandaard.</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>De opgegeven afwijkingen worden door het Medicatieprogramma beoordeeld. Houd <del class="diffchange diffchange-inline">er </del>rekening <del class="diffchange diffchange-inline">mee </del>dat het programma <del class="diffchange diffchange-inline">het </del>mogelijk niet <del class="diffchange diffchange-inline">eens is </del>met de opgegeven afwijkingen. Daarom worden alle afwijkingen met de leverancier besproken. Hier zullen een of meerdere overleggen voor worden ingepland.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>De opgegeven afwijkingen worden door het Medicatieprogramma beoordeeld. Houd rekening <ins class="diffchange diffchange-inline">met het feit </ins>dat het programma mogelijk niet <ins class="diffchange diffchange-inline">instemt </ins>met de opgegeven afwijkingen. Daarom worden alle afwijkingen met de leverancier besproken. Hier zullen een of meerdere overleggen voor worden ingepland.</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Uiteindelijk worden alle afspraken over de non-conformiteiten vastgelegd en wordt <del class="diffchange diffchange-inline">er </del>tijdens de validatie getoetst of hieraan is voldaan.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Uiteindelijk worden alle afspraken over de non-conformiteiten vastgelegd en wordt tijdens de validatie getoetst of hieraan is voldaan.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Zodra alle documenten zijn goedgekeurd, wordt <del class="diffchange diffchange-inline">er een </del>bouwgesprek gepland.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Zodra alle documenten zijn goedgekeurd, wordt <ins class="diffchange diffchange-inline">het </ins>bouwgesprek gepland.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Tijdens dit overleg wordt o.a. besproken wat jullie planning is en of jullie behoefte hebben aan extra informatie. In de voorbereiding op dit overleg kan de leverancier worden gevraagd aanvullende documentatie door te nemen of – afhankelijk van het kennisniveau – een verdiepende cursus te volgen.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Tijdens dit overleg wordt o.a. besproken wat jullie planning is en of jullie behoefte hebben aan extra informatie. In de voorbereiding op dit overleg kan de leverancier worden gevraagd aanvullende documentatie door te nemen of – afhankelijk van het kennisniveau – een verdiepende cursus te volgen.</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">Er kan vanuit </del>het programma Medicatieoverdracht <del class="diffchange diffchange-inline">eventueel </del>extra ondersteuning worden geboden in de vorm van trainingen of kennissessies om jullie als leverancier op weg te helpen.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Vanuit </ins>het programma Medicatieoverdracht <ins class="diffchange diffchange-inline">kan </ins>extra ondersteuning worden geboden in de vorm van trainingen of kennissessies om jullie als leverancier op weg te helpen.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Tijdens het bouwgesprek zullen de kennishouders van het programma Medicatieoverdracht in gesprek gaan over het Technisch Ontwerp (TO), samen met de ontwikkelaars, architecten, product owners en testers van de leverancier. De casemanager is ook aanwezig om gemaakte afspraken te notuleren en eventuele acties uit te zetten.</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Tijdens het bouwgesprek zullen de kennishouders van het programma Medicatieoverdracht in gesprek gaan over het Technisch Ontwerp (TO), samen met de ontwikkelaars, architecten, product owners en testers van de leverancier. De casemanager is ook aanwezig om gemaakte afspraken te notuleren en eventuele acties uit te zetten.</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">Vervolgens kan er worden gestart met </del>het <del class="diffchange diffchange-inline">ontwikkelen </del>en <del class="diffchange diffchange-inline">het inbouwen </del>van het Medicatieproces 9<del class="diffchange diffchange-inline">. Het ontwikkelen is opgedeeld in </del>10 stappen. Zie hiervoor https://www.samenvoormedicatieoverdracht.nl/stappenplan-sectoren/.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Na deze fase start </ins>het <ins class="diffchange diffchange-inline">proces van ontwikkeling </ins>en <ins class="diffchange diffchange-inline">inbouw </ins>van het Medicatieproces 9<ins class="diffchange diffchange-inline">; deze ontwikkeling bestaat uit </ins>10 stappen. Zie hiervoor https://www.samenvoormedicatieoverdracht.nl/stappenplan-sectoren/.</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Vooralsnog <del class="diffchange diffchange-inline">wordt er gestart </del>met de volgende 4 stappen:</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Vooralsnog <ins class="diffchange diffchange-inline">start men </ins>met de volgende 4 stappen:</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_3:_Voorschrijven|Stap 3: Voorschrijven]][[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_4:_Verificatie_en_gebruiken|Stap 4: Verificatie en gebruiken]]</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_3:_Voorschrijven|Stap 3: Voorschrijven]]</div></td></tr> <tr><td colspan="2">&#160;</td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">:*</ins>[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_4:_Verificatie_en_gebruiken|Stap 4: Verificatie en gebruiken]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_5:_Verstrekken|Stap 5: Verstrekken]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_5:_Verstrekken|Stap 5: Verstrekken]]</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_6:_Toedienen|Stap 6: Toedienen]]</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>:*[[mp:V2.0.0_Verwijzing_naar_documentatie_Medicatieproces9_tbv_Kickstart#Stap_6:_Toedienen|Stap 6: Toedienen]]</div></td></tr> </table>

Maud Hellinga